ACUTE MYOCARDIAL-INFARCTION IN A YOUNG BOY WITH NEPHROTIC SYNDROME - A CASE-REPORT AND REVIEW OF THE LITERATURE

被引：31

作者：

HOPP, L

GILBOA, N

KURLAND, G

WEICHLER, N

ORCHARD, TJ

机构：

[1] Division of Nephrology, Children's Hospital of Pittsburgh, Pittsburgh, 15213, PA

[2] Division of Pulmonology, Children's Hospital of Pittsburgh, Pittsburgh, 15213, PA

[3] Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania

来源：

PEDIATRIC NEPHROLOGY | 1994年 / 8卷 / 03期

关键词：

ACUTE MYOCARDIAL INFARCTION; NEPHROTIC SYNDROME; HYPERLIPIDEMIA; PREMATURE ATHEROSCLEROSIS;

D O I：

10.1007/BF00866337

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

A 7-year-old boy with a 5-year history of steroid-unresponsive nephrotic syndrome due to minimal change disease presented with acute myocardial infarction. Angiography was suggestive of a dissected atherosclerotic plaque at the initial and mid portions of the right coronary artery, as well as a lesion in the mid portion of the circumflex artery. The child had a long history of extreme hypercholesterolemia and hypertriglyceridemia, along with apolipoprotein-E 4/3 phenotype. The mother, who also has apolipoprotein-E 4/3 phenotype, has mild hypercholesterolemia. The case suggests that children with long-lasting nephrotic syndrome and even mild familial propensity for hyperlipidemia may be at increased risk for ischemic cardiovascular events. The Literature is reviewed regarding the relationship between nephrotic syndrome and the incidence of ischemic heart disease.

引用

页码：290 / 294

页数：5

共 44 条

[1]

Oetliker O.H., Mordasini R., Lutschg J., Riesen W., Lipoprotein metabolism in nephrotic syndrome in childhood, Pediatr Res, 14, pp. 64-66, (1980)

[2]

Rabelink A.J., Hene R.J., Erkelens D.W., Joles J.A., Koomans H.A., Effects of simvastatin and cholestyramine on lipoprotein profile in hyperlipidemia of nephrotic syndrome, Lancet, 2, pp. 1335-1338, (1988)

[3]

Vega G.L., Grundy S.M., Lovastatin therapy in nephrotic hyperlipidemia: effects on lipoprotein metabolism, Kidney Int, 33, pp. 1160-1168, (1988)

[4]

Baxter J.H., Hyperlipoproteinemia in nephrosis, Arch Intern Med, 109, pp. 742-757, (1962)

[5]

Gofman J.W., Jones H.B., Lindgren F.T., Lyon T.P., Elliott H.A., Strisower B., Blood lipids and human atherosclerosis, Circulation, 2, pp. 161-178, (1950)

[6]

Goldstein J.L., Brown, The low density lipoprotein pathway and its relation to atherosclerosis, Annu Rev Biochem, 46, pp. 897-930, (1977)

[7]

Gordon T., Kannel W.B., Castelli W.P., Dawber T.R., Lipoproteins, cardiovascular disease, and death. The Framingham study, Arch Intern Med, 141, pp. 1128-1131, (1981)

[8]

Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. The pooling project research group, J Chronic Dis, 31, pp. 201-306, (1978)

[9]

Carlson L.A., Bottiger L.E., Serum triglycerides: to be or not to be a risk factor for ischemic heart disease?, Atherosclerosis, 39, pp. 287-291, (1981)

[10]

Schwartz H., Kohn J.L., Lipoid nephrosis. A clinical and pathologic study based on fifteen years observation with special reference to prognosis, American Journal of Diseases of Children, 49, pp. 579-593, (1935)

← 1 2 3 4 5 →